CFTR correctors, a therapy for cystic fibrosis targeted at specific variants (most commonly F508del)
7/8/2024
0:00
6:46
Recent developments in treatment for cystic fibrosis have targeted the underlying genetic defect and these have been life-changing for some patients. Kevin Southern from Alder Hey Children’s Hospital in the UK is an Editor for the Cochrane Cystic Fibrosis Group and an author of the updated review of these corrective therapies, which was published in November 2023. Here he is to tell us about the review.
Otros episodios de "Cochrane Library Podcasts"
No te pierdas ningún episodio de “Cochrane Library Podcasts”. Síguelo en la aplicación gratuita de GetPodcast.